Table 1. Demographic and clinical characteristics of HIV-infected and healthy control subjects.
| Category | Subcategory | HIV+ group | Controls |
| Gender | Males (n) | 57 | 10 |
| Females (n) | 24 | 11 | |
| Total (n) | 81 | 21 | |
| Age (years) | Males mean (range) | 45 (20–65) | 56 (45–70) |
| Females mean (range) | 37 (25–59) | 41 (23–66) | |
| Percentage CD4 (%) | Males mean (range) | 27 (5–53) | NT |
| Females mean (range) | 28 (4–48) | NT | |
| Absolute CD4 (cells/µL) | Males mean (SD, range) | 603 (301, 140–1369) | NT |
| Females mean (SD, range) | 611 (324, 104–1188) | NT | |
| CD4:CD8 ratio | Males mean (SD, range) | 0.63 (0.41, 0.07–2.36) | NT |
| Females mean (SD, range) | 0.71 (0.38, 0.07–1.48) | NT | |
| HIV viral load (copies/ml) | Males mean (SD, range) | 30,905 (84,837, <40–446684) | NT |
| Females mean (SD, range) | 16,662 (43240, <40–173780) | NT | |
| Duration of HIV (years) | Males mean (SD, range) | 8.6 (7.0, 1 mth–24 yrs) | NT |
| Females mean (SD, range) | 8.9 (6.9, 1 mth–24 yrs) | NT | |
| Duration of ART at time of MAM (months) | Males n = 45, mean (SD, range) | 96.3 (77, 1–240) | NT |
| Females n = 22, mean (SD, range) | 67.9 (57.3, 1–192) | NT | |
| Months suppressed (<400cpm) at time MAM | Males n = 42, mean (SD, range) | 49.2 (46.7, 1–184) | NT |
| Females n = 18, mean (SD, range) | 49.8 (43.9, 1–149) | NT | |
| Months suppressed (<40cpm) at time MAM | Males n = 31, mean (SD, range) | 30 (37.8, 2–183) | NT |
| Females n = 17, mean (SD, range) | 30.1 (22.3, 1–66) | NT | |
| ART naïve | Males (n) | 12 | NT |
| Females (n) | 2 | NT |
NT = Not tested.